Guardant Health, Inc.

NasdaqGS:GH 株式レポート

時価総額：US$3.8b

Guardant Health マネジメント

マネジメント 基準チェック /44

Guardant Healthの CEO はHelmy Eltoukhyで、 Jan2013年に任命され、 の在任期間は 11.83年です。 の年間総報酬は$ 11.59Kで、 0.01%給与と100%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の2.13%を直接所有しており、その価値は$ 81.58M 。経営陣と取締役会の平均在任期間はそれぞれ3.5年と3.2年です。

主要情報

Helmy Eltoukhy

最高経営責任者

US$11.6k

報酬総額

CEO給与比率0.009%
CEO在任期間11.8yrs
CEOの所有権2.1%
経営陣の平均在職期間3.5yrs
取締役会の平均在任期間3.2yrs

経営陣の近況

Recent updates

Market Participants Recognise Guardant Health, Inc.'s (NASDAQ:GH) Revenues Pushing Shares 36% Higher

Nov 08
Market Participants Recognise Guardant Health, Inc.'s (NASDAQ:GH) Revenues Pushing Shares 36% Higher

An Intrinsic Calculation For Guardant Health, Inc. (NASDAQ:GH) Suggests It's 44% Undervalued

Oct 25
An Intrinsic Calculation For Guardant Health, Inc. (NASDAQ:GH) Suggests It's 44% Undervalued

Is There Now An Opportunity In Guardant Health, Inc. (NASDAQ:GH)?

Sep 24
Is There Now An Opportunity In Guardant Health, Inc. (NASDAQ:GH)?

Guardant Health: Top-Line Growth Undeniable, Compounding Ability Remains Unseen

Aug 21

Guardant Health, Inc.'s (NASDAQ:GH) P/S Is Still On The Mark Following 26% Share Price Bounce

Jul 31
Guardant Health, Inc.'s (NASDAQ:GH) P/S Is Still On The Mark Following 26% Share Price Bounce

Guardant Health, Inc. (NASDAQ:GH) Shares Could Be 49% Below Their Intrinsic Value Estimate

Jul 12
Guardant Health, Inc. (NASDAQ:GH) Shares Could Be 49% Below Their Intrinsic Value Estimate

Guardant: Double-Digit Sales Projections Come At A Cost

Jun 06

Is Now The Time To Look At Buying Guardant Health, Inc. (NASDAQ:GH)?

Jun 04
Is Now The Time To Look At Buying Guardant Health, Inc. (NASDAQ:GH)?

Investors Appear Satisfied With Guardant Health, Inc.'s (NASDAQ:GH) Prospects As Shares Rocket 31%

May 14
Investors Appear Satisfied With Guardant Health, Inc.'s (NASDAQ:GH) Prospects As Shares Rocket 31%

Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

Mar 29
Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

With Guardant Health, Inc. (NASDAQ:GH) It Looks Like You'll Get What You Pay For

Jan 21
With Guardant Health, Inc. (NASDAQ:GH) It Looks Like You'll Get What You Pay For

Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

Nov 20
Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

Is There Now An Opportunity In Guardant Health, Inc. (NASDAQ:GH)?

Sep 26
Is There Now An Opportunity In Guardant Health, Inc. (NASDAQ:GH)?

A Look At The Fair Value Of Guardant Health, Inc. (NASDAQ:GH)

Sep 05
A Look At The Fair Value Of Guardant Health, Inc. (NASDAQ:GH)

Is Guardant Health (NASDAQ:GH) A Risky Investment?

Aug 15
Is Guardant Health (NASDAQ:GH) A Risky Investment?

A Look At The Intrinsic Value Of Guardant Health, Inc. (NASDAQ:GH)

May 28
A Look At The Intrinsic Value Of Guardant Health, Inc. (NASDAQ:GH)

Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

Apr 05
Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

Is Guardant Health (NASDAQ:GH) Using Too Much Debt?

Dec 28
Is Guardant Health (NASDAQ:GH) Using Too Much Debt?

CEO報酬分析

Guardant Health の収益と比較して、Helmy Eltoukhy の報酬はどのように変化したか？
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$512m

Jun 30 2024n/an/a

-US$491m

Mar 31 2024n/an/a

-US$461m

Dec 31 2023US$12kUS$1

-US$479m

Sep 30 2023n/an/a

-US$432m

Jun 30 2023n/an/a

-US$508m

Mar 31 2023n/an/a

-US$665m

Dec 31 2022US$12kUS$1

-US$655m

Sep 30 2022n/an/a

-US$606m

Jun 30 2022n/an/a

-US$551m

Mar 31 2022n/an/a

-US$419m

Dec 31 2021US$14kUS$1

-US$406m

Sep 30 2021n/an/a

-US$409m

Jun 30 2021n/an/a

-US$379m

Mar 31 2021n/an/a

-US$336m

Dec 31 2020US$114mUS$210k

-US$254m

Sep 30 2020n/an/a

-US$185m

Jun 30 2020n/an/a

-US$120m

Mar 31 2020n/an/a

-US$77m

Dec 31 2019US$915kUS$500k

-US$76m

Sep 30 2019n/an/a

-US$76m

Jun 30 2019n/an/a

-US$87m

Mar 31 2019n/an/a

-US$97m

Dec 31 2018US$818kUS$480k

-US$85m

Sep 30 2018n/an/a

-US$75m

Jun 30 2018n/an/a

-US$84m

Mar 31 2018n/an/a

-US$83m

Dec 31 2017US$4mUS$460k

-US$89m

報酬と市場: Helmyの 総報酬 ($USD 11.59K ) は、 US市場 ($USD 6.60M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Helmyの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Helmy Eltoukhy (45 yo)

11.8yrs

在職期間

US$11,591

報酬

Dr. Helmy Eltoukhy, Ph D., is Partner of Green Sands Equity Incorporated. He is Equity Partner and Advisor of Transform VC.Dr. Eltoukhy has been the Chairman of the Board of Directors of Guardant Health,...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Helmy Eltoukhy
Co-Founder11.8yrsUS$11.59k2.13%
$ 81.6m
AmirAli Talasaz
Co-CEO & Director3.3yrsUS$26.42k2.2%
$ 84.4m
Michael Bell
Chief Financial Officer3.8yrsUS$4.12m0.019%
$ 746.0k
Darya Chudova
Chief Technology Officerno dataUS$4.76m0.044%
$ 1.7m
Craig Eagle
Chief Medical Officer3.5yrsUS$3.49m0.019%
$ 720.8k
Christopher Freeman
Chief Commercial Officer3.4yrsUS$3.52m0.025%
$ 974.5k
Kumud Kalia
Chief Information Officer4.8yrsデータなし0.014%
$ 549.7k
Zarak Khurshid
Vice President of Investor Relationsno dataデータなしデータなし
John Saia
Chief Legal Officer & Corporate Secretary4.5yrsUS$6.02m0.027%
$ 1.0m
Jennifer Higgins
Senior Vice President of Public Affairsno dataデータなしデータなし
Stephen Murphy
Senior Vice President of Marketingless than a yearデータなしデータなし
Terilyn Monroe
Chief People Officerless than a yearデータなしデータなし

3.5yrs

平均在職期間

51yo

平均年齢

経験豊富な経営陣: GHの経営陣は 経験豊富 であると考えられます ( 3.5年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Helmy Eltoukhy
Co-Founder11.8yrsUS$11.59k2.13%
$ 81.6m
AmirAli Talasaz
Co-CEO & Director11.8yrsUS$26.42k2.2%
$ 84.4m
Myrtle Potter
Independent Director3.1yrsUS$425.21k0.011%
$ 423.0k
Ian T. Clark
Lead Independent Director7.8yrsUS$470.21k0.0068%
$ 261.4k
Roberto Mignone
Directorless than a yearデータなしデータなし
Steve Krognes
Independent Director2.4yrsUS$425.21k0.0080%
$ 307.0k
Musa Tariq
Independent Director1.7yrsUS$725.30k0.0040%
$ 154.6k
Vijaya Gadde
Independent Director4.4yrsUS$425.21k0.014%
$ 546.6k
Meghan Joyce
Independent Director3.3yrsUS$425.21k0.0062%
$ 236.9k
Manuel Medina
Directorless than a yearデータなしデータなし

3.2yrs

平均在職期間

50.5yo

平均年齢

経験豊富なボード: GHの 取締役会 は 経験豊富 であると考えられます ( 3.2年の平均在任期間)。